2026 NPPES data Hematology & Oncology Physician NPI 1952362394 MD
Verify on CMS →

MARK WESTBERG, MD

Hematology & Oncology Physician in ANKENY, Iowa. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 135 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MARK WESTBERG, MD filed 1,153 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in ANKENY, Iowa, prescribing 85% generic.

1K
Part D claims, 2023
85%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK WESTBERG, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,153 Top 23% higher than 77% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MARK WESTBERG, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK WESTBERG, MD?

Quality data not reported

NPI registry status

Active

Issued 03/28/2006

NPI 1952362394

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,153 36% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Iowa

How Hematology & Oncology Physician compares to other specialties among Iowa providers

Iowa providers

Hematology & Oncology Physician share within Iowa

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Iowa

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK WESTBERG, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 1950 SW MAGAZINE RD, ANKENY, IA, 50023, with a listed phone of (515) 282-2921. NPI 1952362394 was issued on 03/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WESTBERG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,153 prescription claims written by this provider, covering 135 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 18.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1950 SW MAGAZINE RD
ANKENY, IA 50023

Provider Details

NPI 1952362394
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 03/28/2006

Hospital and facility affiliations

Facilities where MARK WESTBERG, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ST ANTHONY REGIONAL HOSPITAL AND NURSING HOME
CARROLL, IA
STATE UNIVERSITY OF IOWA
ANKENY, IA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

MARK WESTBERG, MD — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 1,153 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,153
Total Claims
$2.1M
Total Drug Cost
135
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,445
Total Day Supply
38,645
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$1.9M
Generic Drug Cost
$210K
Opioid Claims
208 (18.0% rate)
Antibiotic Claims
49

Patient Demographics

Average Patient Age
73.9 years
Avg HCC Risk Score
1.86
Gender Split
67% female / 33% male
Age Distribution
<65: 12, 65-74: 67, 75-84: 41, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK WESTBERG, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
231
Letrozole
69
Fentanyl
56
Ondansetron Hcl
49
Prednisone
49
Gabapentin
47
Oxycodone Hcl
45
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
41
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
33
Hydromorphone Hcl
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MARK WESTBERG, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MARK WESTBERG, MD's 1,153 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Iowa

Other clinicians with the same primary specialty enrolled in Iowa, drawn from the same CMS NPPES roster as WESTBERG.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK WESTBERG, MD's specialty?
MARK WESTBERG, MD specializes in Hematology & Oncology Physician and practices in ANKENY, Iowa. Credentials: MD.
How much does MARK WESTBERG, MD prescribe under Medicare Part D?
In 2023, MARK WESTBERG, MD wrote 1,153 Medicare Part D claims totaling $2.1M in drug costs for 135 beneficiaries.
Where is MARK WESTBERG, MD located?
MARK WESTBERG, MD is located at 1950 SW MAGAZINE RD, ANKENY, IA, 50023. Phone: (515) 282-2921.
What is MARK WESTBERG, MD's NPI number?
MARK WESTBERG, MD's National Provider Identifier (NPI) is 1952362394, issued on 03/28/2006.
Does MARK WESTBERG, MD prescribe more brand-name or generic drugs?
MARK WESTBERG, MD's prescribing is 15% brand-name and 85% generic drugs by claim count, with $1.9M in brand drug costs.
Does MARK WESTBERG, MD prescribe opioids?
Yes, MARK WESTBERG, MD had 208 opioid claims in 2023 with an opioid prescribing rate of 18.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MARK WESTBERG, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK WESTBERG, MD's most frequently prescribed drugs include Anastrozole, Letrozole, Fentanyl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK WESTBERG, MD accept Medicare?
MARK WESTBERG, MD appears in CMS Medicare data with 1,153 Part D claims and 135 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK WESTBERG, MD's credentials?
MARK WESTBERG, MD's NPI is 1952362394 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology